We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -7.02% | 1.325 | 1.30 | 1.35 | 1.425 | 1.325 | 1.43 | 2,958,047 | 14:52:56 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.25 | 10.24M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/4/2024 16:07 | Re review world, conversation = "let's make a lowball offer for the rest of the shares which this weak and shareholer unfriendly mgmt will accept and who cares about the small retail shareholders.. " | cordwainer | |
24/4/2024 15:29 | If you're the major shareholder, I wonder what conversation you're having internally | reviewwworld | |
24/4/2024 15:00 | Well Scott I would be extremely happy to be 90% down here.Would love nothing more than to be completely wrong but this CEO has been worse than the previous which seemed impossible | best1467 | |
24/4/2024 10:34 | From day 1 I assigned zero value to Edison research. I mean, STX pay them to write it. It's like asking your best mate to write your school report. Mad that such a thing exists, sad that such a thing is permitted by the FCA. | reviewwworld | |
24/4/2024 00:57 | re weatherman - of course, makes more sense than my mini-rant. | cordwainer | |
23/4/2024 19:19 | Edison wrong, misled or exaggerated the research. Surly if the company starts to miss quarterly figures and you keep egging it on, you are partly to blame as investors use such research papers to get some insight into the business. | razoblade | |
23/4/2024 13:48 | It means STX are cutting costs to the bone. | weatherman | |
23/4/2024 13:41 | Edison announced terminating coverage along with a clutch of other small companies. Possibly because they know they were wrong. | cordwainer | |
22/4/2024 13:13 | The reason it’s a relentless is the inside knowledge of what’s on its way .A possible default on the revenue number potentially a capital Regig which would inevitably lead to massive dilution. The only certainty is we will get the usual painful news | best1467 | |
17/4/2024 12:59 | They answer questions in these meetings, but not enough. They should show more info how to save money to get through the periods before H2 2025. | qipincha | |
17/4/2024 12:50 | You can not ask any questions it’s staged and they pick the ones they posted themselves it’s a staged farce | best1467 | |
17/4/2024 10:04 | Very difficult to be a big player when your share price is languishing at all time lows and difficult to raise monies without more dilution. A very promising Company years ago, management must take full responsibility for the current debacle | ny boy | |
16/4/2024 07:19 | Results 30 April, when you can ask your Qs. | weatherman | |
15/4/2024 13:38 | Execs and esp CEO (and maybe even NEDS) should take a pay cut they are way above average for the market cap and pocketing a significant chunk of revenue at every other shareholders expense. | cordwainer | |
12/4/2024 16:05 | RI out of the frying pan and into the fire, white board members fail in darkest Africa, it's a pay back for colonialism! TRP is a duffer, always looking for never ending money to finance, just confetti shares how many in issue now, must be 16 Billion + 🤡😂)0 | ny boy | |
11/4/2024 12:16 | Missed a bullet now stood in front of an ak47 with TRPHa ha | bimbamboom | |
10/4/2024 12:33 | Was it a Hardman researh report ?? | riskyinvestor | |
10/4/2024 12:33 | I was going to buy these at 8p last year because of a research report which said they are worth around 50p I missed a bullet Am in Tower Resources (TRP) Where if funds allow I will be topping up every month if it stays at the 0.02p levels | riskyinvestor | |
09/4/2024 22:57 | It was a half decent day until 4 o clock.Next update is crucial and I can't believe we can't exploit this FDA approved drug to create a profitable business and an share price many multiples of the current price.But then wtfdik. | husbod | |
09/4/2024 10:12 | Yes, market size is tiny | qipincha |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions